Chengdu Kanghua Biological Products Co (SZSE:300841) Accounts Payable & Accrued Expense : ¥378 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Chengdu Kanghua Biological Products Co Accounts Payable & Accrued Expense?

Chengdu Kanghua Biological Products Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥385 Mil) to Dec. 2023 (¥491 Mil) but then declined from Dec. 2023 (¥491 Mil) to Mar. 2024 (¥378 Mil).

Chengdu Kanghua Biological Products Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥338 Mil) to Dec. 2022 (¥501 Mil) but then declined from Dec. 2022 (¥501 Mil) to Dec. 2023 (¥491 Mil).

Chengdu Kanghua Biological Products Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Chengdu Kanghua Biological Products Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Kanghua Biological Products Co Accounts Payable & Accrued Expense Chart

Chengdu Kanghua Biological Products Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

103.04

170.33

338.34

500.86

490.51

Chengdu Kanghua Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															421.34	383.73	385.12	490.51	378.15

Chengdu Kanghua Biological Products Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Chengdu Kanghua Biological Products Co (SZSE:300841) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Kanghua Biological Products Co Ltd (SZSE:300841) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 182, Beijing Road, Chengdu Economic and Technological Development Zone, Sichuan Province, Chengdu, CHN, 610100

Website

https://www.kangh.com

Chengdu Kanghua Biological Products Co Ltd is engaged in research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine (human diploid cell) for Human Use, freeze-dried - HDCV. The company's products include ACYW135 Meningococcal Polysaccharide Vaccine; and Rabies Vaccine.

Chengdu Kanghua Biological Products Co (SZSE:300841) Headlines

No Headlines